The visualisation of vitreous using surface modified poly(lactic-co-glycolic acid) microparticles.
AIMS To demonstrate the potential use of in vitro poly(lactic-co-glycolic acid) (PLGA) microparticles in comparison with triamcinolone suspension to aid visualisation of vitreous during anterior and posterior vitrectomy. METHODS PLGA microparticles (diameter 10-60 microm) were fabricated using single and/or double emulsion technique(s) and used untreated or following the surface adsorption of a protein (transglutaminase). Particle size, shape, morphology and surface topography were assessed using scanning electron microscopy (SEM) and compared with a standard triamcinolone suspension. The efficacy of these microparticles to enhance visualisation of vitreous against the triamcinolone suspension was assessed using an in vitro set-up exploiting porcine vitreous. RESULTS Unmodified PLGA microparticles failed to adequately adhere to porcine vitreous and were readily washed out by irrigation. In contrast, modified transglutaminase-coated PLGA microparticles demonstrated a significant improvement in adhesiveness and were comparable to a triamcinolone suspension in their ability to enhance the visualisation of vitreous. This adhesive behaviour also demonstrated selectivity by not binding to the corneal endothelium. CONCLUSION The use of transglutaminase-modified biodegradable PLGA microparticles represents a novel method of visualising vitreous and aiding vitrectomy. This method may provide a distinct alternative for the visualisation of vitreous whilst eliminating the pharmacological effects of triamcinolone acetonide suspension.
Chau
David Y S
DY
Wolfson Centre for Stem Cells, Tissue Engineering and Modelling, Centre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
Tint
Naing L
NL
Collighan
Russell J
RJ
Griffin
Martin
M
Dua
Harminder S
HS
Shakesheff
Kevin M
KM
Rose
Felicity R A J
FR
D000268:Adhesiveness; D006016:Glycolates / Q000737:chemistry*; D006801:Humans; D066298:In Vitro Techniques; D019344:Lactic Acid; D008855:Microscopy, Electron, Scanning; D008863:Microspheres; D010316:Particle Size; D011100:Polyglycolic Acid; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D014221:Triamcinolone; D014821:Vitrectomy / Q000379:methods; D014822:Vitreous Body / Q000473:pathology*
D006016:Glycolates; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D014221:Triamcinolone; D011100:Polyglycolic Acid; D019344:Lactic Acid
Retina. 2008 Feb;28(2):333-9
18301040
Eye (Lond). 2010 May;24(5):888-93
19680280
Biochem J. 2002 Dec 1;368(Pt 2):377-96
12366374
J Cataract Refract Surg. 2006 Sep;32(9):1549-55
16931271
Biomaterials. 2005 Nov;26(33):6518-29
15927250
Acta Ophthalmol. 2008 Feb;86(1):97-102
17908254
J Biotechnol. 2001 Mar 30;86(2):135-50
11245902
J Cataract Refract Surg. 1999 May;25(5):705-8
10330649
Adv Drug Deliv Rev. 2001 Oct 31;52(1):5-16
11672871
J Cataract Refract Surg. 2007 Dec;33(12):2122-8
18053915
Surv Ophthalmol. 2009 Sep-Oct;54(5):576-617
19682624
Adv Drug Deliv Rev. 2007 May 30;59(4-5):187-206
17540473
Nat Rev Mol Cell Biol. 2003 Feb;4(2):140-56
12563291
Curr Eye Res. 1995 Sep;14(9):761-8
8529414
J Biomed Mater Res. 2001 Feb;54(2):294-304
11093190
Am J Ophthalmol. 2004 Oct;138(4):650-2
15488797
Eye (Lond). 2006 Aug;20(8):951-5
16123782
Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3277-82
17591899
J Cataract Refract Surg. 2003 Apr;29(4):645-51
12686230
Nat Protoc. 2009;4(10):1440-53
19798079
Arch Biochem Biophys. 2008 Sep 15;477(2):379-83
18616926
Br J Ophthalmol. 2007 Sep;91(9):1101-2
17709577
Amino Acids. 2009 Apr;36(4):619-24
18651094
Biomaterials. 2005 Jun;26(16):3075-82
15603802
Appl Microbiol Biotechnol. 2004 May;64(4):447-54
14740191
J Bone Joint Surg Am. 1997 Feb;79(2):185-93
9052538
Eye (Lond). 2007 Jun;21(6):812-8
16751761
Clin Ophthalmol. 2008 Dec;2(4):891-6
19668443
J Biol Chem. 2004 Nov 12;279(46):47754-62
15326185
Br J Ophthalmol. 2009 Feb;93(2):268-70
19174403
Biomaterials. 2008 Mar;29(7):857-68
18031807
Curr Opin Ophthalmol. 2008 Jan;19(1):36-40
18090896